Camille L Bedrosian is Chief Medical Officer of Amylyx Pharmaceuticals, Inc.. Currently has a direct ownership of 143,801 shares of AMLX, which is worth approximately $713,252. The most recent transaction as insider was on Sep 30, 2024, when has been sold 11,442 shares (Common Stock) at a price of $3.2 per share, resulting in proceeds of $36,614. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 144K
7.37% 3M change
n/a 12M change
Total Value Held $713,252

Camille L Bedrosian Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 30 2024
SELL
Open market or private sale
$36,614 $3.2 p/Share
11,442 Reduced 7.37%
143,801 Common Stock
Apr 16 2024
BUY
Grant, award, or other acquisition
-
96,910 Added 38.43%
155,243 Common Stock
Nov 27 2023
BUY
Grant, award, or other acquisition
-
58,333 Added 50.0%
58,333 Common Stock

Also insider at

CRNX
Crinetics Pharmaceuticals, Inc. Healthcare
RARE
Ultragenyx Pharmaceutical Inc. Healthcare
RYTM
RHYTHM PHARMACEUTICALS, INC. Healthcare
CLB

Camille L Bedrosian

Chief Medical Officer
San Diego, CA

Track Institutional and Insider Activities on AMLX

Follow Amylyx Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMLX shares.

Notify only if

Insider Trading

Get notified when an Amylyx Pharmaceuticals, Inc. insider buys or sells AMLX shares.

Notify only if

News

Receive news related to Amylyx Pharmaceuticals, Inc.

Track Activities on AMLX